Potential partners or acquiring companies have access to everything they need to assess the potential damages of any lawsuits, arbitration cases, audits, FDA holds, or SEC investigations/claims. Which they then weight with the cost of the deal and what kind of money they can make from said deal over the long term. Knowing all of this information hasn't scared away any current employees, nor has it deterred private investors from slapping their cash on the table to deliver funding. We all continue to hold and/or acquire, and believe most or all of the concerns are ultimately not that big of a deal. So no, I don't think any potential partners out there would have trouble doing the same and making a move before these ongoing concerns have officially played themselves out. Hell, if Cytodyn and Sidley lay out the case for suing Amarex down the road, and it's pointing toward as substantial an award as we all think it could/should be, none of the other stuff would even matter. They could maybe make their money back just from that lawsuit.